Trials / Sponsors / SHINKEI Therapeutics, Inc
SHINKEI Therapeutics, Inc
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Study to Assess the Safety of Amantadine Hydrochloride (HCl) Intravenous (IV) Solution (MR-301) in Patients Wi Traumatic Brain Injury | Phase 2 | 2024-06-01 |